ArticleAnnals of translational medicine2022

GRSF1 predicts an unfavorable prognosis and promotes tumorigenesis in lung adenocarcinoma based on bioinformatics analysis and

Rong Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.